Gingivitis has been linked to adverse pregnancy outcome (APO). Bacterial vaginosis (BV) has been associated with APO. We assessed if bacterial counts in BV is associated with gingivitis suggesting a systemic infectious susceptibilty.
Methods
Vaginal samples were collected from 180 women (mean age 29.4 years, SD ± 6.8, range: 18 to 46), and at least six months after delivery, and assessed by semi-quantitative DNA-DNA checkerboard hybridization assay (74 bacterial species). BV was defined by Gram stain (Nugent criteria). Gingivitis was defined as bleeding on probing at ≥ 20% of tooth sites.
Results
A Nugent score of 0–3 (normal vaginal microflora) was found in 83 women (46.1%), and a score of > 7 (BV) in 49 women (27.2%). Gingivitis was diagnosed in 114 women (63.3%). Women with a diagnosis of BV were more likely to have gingivitis (p = 0.01). Independent of gingival conditions, vaginal bacterial counts were higher (p < 0.001) for 38/74 species in BV+ in comparison to BV- women. Counts of four lactobacilli species were higher in BV- women (p < 0.001). Independent of BV diagnosis, women with gingivitis had higher counts of Prevotella bivia (p < 0.001), and Prevotella disiens (p < 0.001). P. bivia, P. disiens, M. curtisii and M. mulieris (all at the p < 0.01 level) were found at higher levels in the BV+/G+ group than in the BV+/G- group. The sum of bacterial load (74 species) was higher in the BV+/G+ group than in the BV+/G- group (p < 0.05). The highest odds ratio for the presence of bacteria in vaginal samples (> 1.0 × 104 cells) and a diagnosis of gingivitis was 3.9 for P. bivia (95% CI 1.5–5.7, p < 0.001) and 3.6 for P. disiens (95%CI: 1.8–7.5, p < 0.001), and a diagnosis of BV for P. bivia (odds ratio: 5.3, 95%CI: 2.6 to 10.4, p < 0.001) and P. disiens (odds ratio: 4.4, 95% CI: 2.2 to 8.8, p < 0.001).
Conclusion
Higher vaginal bacterial counts can be found in women with BV and gingivitis in comparison to women with BV but not gingivitis. P. bivia and P. disiens may be of specific significance in a relationship between vaginal and gingival infections.
The online version of this article (doi:10.1186/1471-2334-9-6) contains supplementary material, which is available to authorized users.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GRP, JH, DE, MV, MT and RV designed the study. MR collected clinical dental data and JH was in charge of medical examinations. REP analyzed the radiographs and defined the periodontal diagnosis. KP coordinated the study and established the clinical database (medical and dental). MW and RH processed the microbiological material and developed the probes. RV, MT and MV provided and confirmed the accuracy of the bacteria. GRP was responsible for the data analysis. All co-authors contributed to the preparation of the manuscript.
Background
Adverse preterm outcomes occur in approximately 10% of all pregnancies [1]. It remains a major source of neonatal morbidity and mortality. The prevalence of periodontitis in women of childbearing age is unknown. Gingivitis is a reversible inflammatory condition of keratinized and non-keratinized gum tissues surrounding the teeth. Periodontitis is a non-reversible inflammatory condition that also includes loss of alveolar bone and other tooth supporting structures. Infection with a diverse microflora is the etiology of both these conditions. The association between gingivitis or periodontitis and an increased risk of preterm birth remains a matter of dispute. Several recent studies support the hypothesis that periodontal infectious disease is a risk factor for adverse pregnancy outcomes [2‐8]. One hypothesized mechanism is that inflammation may upregulate the inflammatory response in anatomically distinct locations such as the uterus and the amniotic cavity [7‐9].
Bacterial vaginosis (BV), a condition characterized by decreased vaginal lactobacilli and increased anaerobic bacteria, has been associated with an increased risk of preterm birth [10, 11]. The abnormal microflora typical of BV overlaps considerably with bacterial species known to be associated with periodontal disease. For example, Prevotella bivia and Porphyromonas sp. have been associated with BV [12], whereas Prevotella intermedia and Porphyromonas gingivalis have been associated with periodontal disease [13, 14]. Higher counts of colony forming units of P. gingivalis in subgingival samples have also been observed in women who subsequently delivered prematurely [8, 15]. Despite such findings, the biological relationship between oral and vaginal infections has not been extensively studied.
Anzeige
The purpose of the present study was to characterize the bacterial species in vaginal samples from women of childbearing age in relation to clinical evidence of gingival inflammation (gingivitis) and bacterial vaginosis. We hypothesized that the vaginal microflora differed between women with or without overt clinical evidence of gingivitis. We also hypothesized a co-occurrence of BV and gingivitis.
Methods
The Human Research Review Board of the Washington State Department of Health approved the study. All subjects signed informed written consent as required by the IRB. The study cohort included parous women with no known systemic disease, who were recruited based on a previous history of early preterm delivery (20–34 weeks gestation) or term delivery (≥ 37 weeks gestation). A preterm birth occurred among 17 (9.2%) of the women participating in the present study. All women had delivered at least 6 months prior to study entry and microbiological sampling.
The women had a gynecological examination with collection of vaginal by insertion of a Dacron swab into the vaginal vault. One swab was used to prepare an air-dried slide for Gram stain for BV diagnosis according to the Nugent criteria [11]. A second swab tip was placed in a cryovial eluted in 0.9 ml phosphate buffered saline and stored at -80°C until transported on dry ice by express courier to the Oral Microbiology Laboratory at the University of Berne, Switzerland, for analysis of microbial content.
Women also had a standard periodontal examination at the Regional Clinical Dental Research Center (RCDRC), School of Dentistry at the University of Washington, Seattle, WA. Gingivitis was defined as having ≥ 20% of gingival sites surfaces (six examined per tooth) with bleeding on probing (BOP). This cutoff level is considered a useful criterion to establish gingivitis and is used as a basic principle in the standard practice of periodontal care. Clinical probing pocket depths around all teeth and intra-oral radiographs were also assessed to define if the women also had a diagnosis of periodontitis (alveolar bone loss and evidence of increased probing pocket depth/clinical attachment loss).
Anzeige
A total of 180 women who had given birth at least six months prior to enrollment were included in this analysis. Their mean age was 29.4 years (SD ± 6.8, range: 18 to 46). The racial groups were as follows: 60 Caucasians (32.6%), 82 African-Americans (44.6%), 9 Native Americans (4.9%), and 33 of other races (17.9%).
Microbiological processing
At the microbiology laboratory, 300 μl Tris EDTA buffer (10 mM Tris-HCL, 1.0 mM EDTA, pH 7.6) was added to each vial with a vaginal swab, allowed to stand for 10 minutes, and was then sonicated for 10 seconds. Subsequently, 200 μl of freshly made 0.5 M NaOH was added to each vial and the swab was removed before freezing the sample. Samples were then processed within three months. Before processing, the samples were diluted fourfold with Tris EDTA buffer and aliquoted into two vials. These were processed by the checkerboard DNA-DNA hybridization method as described in detail elsewhere [16‐19]. DNA probes used in the checkerboard DNA-DNA format provide a useful tool for the enumeration of bacterial species in microbiologically complex systems [17]. One vial was used to check for the presence of the species of which probes were present on the first panel, the other vial for the species of the second panel (Table 1). The information was digitized and analyzed by the software program ImageQuant (Amersham Pharmacia, Piscataway, NJ) allowing comparison of signal intensities against standard lanes containing DNA extracted from 105 and 106 bacterial cells in the appropriate checkerboard slot for all species. Routine laboratory assessment of the reproducibility suggested a very high level of reliability varying within species by 1–2%. Signals were converted to semi-quantitative counts by comparison with these standards. For dichotomous analysis of the data, a signal strength of ≥ 1 × 104 bacterial cells was considered as positive. The species that were studied are listed in Table 1. The species listed in Panel 1 are commonly assessed by the checkerboard DNA-DNA hybridization method in studies of bacteria associated with periodontitis [19, 20]. These were either part of the original microbiological laboratory library of species [19, 20] or had been provided by the Department of Clinical Chemistry, Microbiology and Immunology at the University of Ghent, Belgium (UGent). Some species or DNA had been purchased from LGC Promochem, Molsheim, France. The identification of species from the University of Ghent has been described elsewhere [21‐24]. Thus the bacteria listed in Panel 2 are commonly assessed in studies of BV.
Table 1
Bacterial species and subspecies included in the DNA-DNA checkerboard assay
Species Panel 1
Collection*
Species Panel 2
Collection*
1a. Aggregatibacter actinomycetemcomitans (a)
ATCC 29523
1. Actinomyces neuii
GUH 550898
1b. Aggregatibacter actinomycetemcomitans (Y4)
ATCC 43718
2. Aerococcus christensenii
GUH 070938
2. Actinomyces israelii
ATCC 12102
3. Anaerococcus vaginalis
GUH 290486
3. Actinomyces naeslundii (type I + II)
ATCC 43146
4. Atopobium parvulum
GUH 160323
4. Actinomyces odontolyticum
ATCC 17929
5. Atopobium vaginae
GUH 010535
5. Campylobacter gracilis
ATCC 33236
6. Bacteroides ureolyticus
GUH 080189
6. Campylobacter rectus
ATCC 33238
7. Bifidobacterium biavatii
GUH 071026
7. Campylobacter showae
ATCC 51146
8. Bifidobacterium bifidum
GUH 070962
8. Capnocytophaga gingivalis
ATCC 33612
9. Bifidobacterium breve
GUH 080484
9. Capnocytophaga ochraceae
ATCC 33596
10. Bifidobacterium longum
GUH 180689
10. Capnocytophaga sputigena
ATCC 33612
11. Corynebacterium aurimucosum
GUH 450453
11. Eikenella corrodens
ATCC 23834
12. Corynebacterium nigricans
GUH 071035
12. Eubacterium saburreum
ATCC 33271
13. Dialister sp.
GUH071045
13a. Fusobacterium nucleatum subsp. Nucleatum
ATCC 25586
14a. Enterococcus faecalis
GUH170812
13b. Fusobacterium nucleatum subsp. Polymorphum
ATCC 10953
14b. Enterococcus faecalis
ATCC 29212
13c. Fusobacterium nucleatum subsp.Naviforme
ATCC 49256
15. Escherichia coli
GUH 070903
14. Fusobacterium periodonticum
ATCC 33693
16. Gardnerella vaginalis
GUH 080585
15. Lactobacillus acidophilus
ATCC 11975
17. Haemophilus influenzae
ATCC 49247
16. Leptotrichia buccalis
ATCC 14201
18. Helicobacter pylori
ATCC 43504
17. Parvimonas micra
ATCC 19696
19. Lactobacillus crispatus
GUH 160342
18. Neisseria mucosa
ATCC 33270
20. Lactobacillus gasseri
GUH 170856
19. Prevotella intermedia
ATCC 25611
21. Lactobacillus iners
GUH 160334
20. Prevotella melaninogenica
ATCC 25845
22. Lactobacillus jensenii
GUH 160339
21. Prevotella nigrescens
ATCC 33563
23. Lactobacillus vaginalis
GUH 0780928
22. Porphyromonas gingivalis
ATCC 33277
24. Mobiluncus curtisii
GUH 070927
23. Propionibacterium acnes (type I+II)
ATCC11827/28
25. Mobiluncus mulieris
GUH 070926
24. Selenomonas noxia
ATCC 43541
26. Peptoniphilus sp.
GUH 550970
25. Staphylococcus aureus
ATCC 25923
27. Porphyromonas endodontalis
ATCC35406
26. Streptococcus anginosus
ATCC 33397
28. Peptostreptococcus anaerobius
GUH 160362
27. Streptococcus constellatus
ATCC 27823 (M32b)
29. Prevotella bivia
GUH 450429
28. Streptococcus gordonii
ATCC 10558
30. Prevotella disiens
GUH 190184
29. Streptococcus intermedius
ATCC 27335
31. Prevotella mirabilis
GUH 070918
30. Streptococcus mitis
ATCC 49456
32. Pseudomonas aeruginosa
ATCC 33467
31. Streptococcus oralis
ATCC 35037
33a. Staphylococcus aureus (yellow)
GUH 070921
32. Streptococcus sanguinis
ATCC 10556
33b. Staphylococcus aureus (white)
GUH 070922
33. Streptococcus mutans
ATCC 25175
34. Staphylococcus epidermidis
GUH 130381
34. Tannerella forsythia
ATCC 43037 (338)
35. Staphylococcus haemolyticus
GUH071047
35. Treponema denticola
ATCC 35405
36. Streptococcus agalactiae
GUH 230282
36. Treponema socranskii
D40DR2
37. Varibaculum cambriense
GUH 070917
37. Veillonella parvula
ATCC 10790
Legend: * ATCC: American Type Culture Collection; D: sample from Forsyth Institute, Massachusetts; GUH: Ghent University Hospital Collection, Ghent, Belgium
Statistical methods
We used One-way ANOVA (Bonferonni post-hoc test) and non-parametric Mann-Whitney U tests, and Kruskal-Wallis ANOVA to assess differences in the quantity of each bacterial species by defined group. Adjustment for multiple comparisons was made and a statistically significant difference was defined by p < 0.001. P-values < 0.01 and < 0.05 were considered as trends of difference. Mantel-Haenszel common odds ratios, sensitivity, and specificity estimations were calculated in order to assess the predictive utility of each vaginal bacterial species in diagnosing gingivitis. The SPSS statistical software 16.0 for MAC OS X was used for the analysis (SPSS Inc., Chicago, IL).
Results
A Nugent score of 0–3, considered as indicative for normal vaginal microflora without signs of inflammation, was found in 83 women (46.1%), and a score of > 7, i.e. clear BV was present in 49 women (27.2%). A total of 38 women (21.1%) had both BV and gingivitis, 54 (30.0%) showed no evidence of either BV or gingivitis, 17 (9.4%) had BV but not gingivitis, and 71 (39.4%) had gingivitis but not BV. Women with a diagnosis of BV had a higher proportion of tooth surfaces with evidence of gingivitis (p = 0.007).
The vaginal microflora of women in relation to a diagnosis of bacterial vaginosis, and independent of gingival conditions
The bacterial species assessed are identified in Table 1. The presence of streptococci, staphylococci and enterococci studied did not differ by BV status. In vaginal samples from women with BV, but independent of gingival status significantly higher bacterial loads (p < 0.001) were observed for the following 38/74 species: A. actinomycetemcomitans (Y4,), A. israelii, A. naeslundi, A. neuii, A. odontolyticus, A. christensenii, B. biavatii, B. longum, B. ureolyticus, C. gingivalis, C. aurimucosum, C. ochraceae, C. sputigena, C. gracilis, C. rectus, C. showae, E. coli, E. corrodens, F. nucl. naviforme, F. nucl. nucleatum, F. nucl. polymorphum, F. periodonticum, H. influenzae, M. curtisii, M. mulieris, P. micra, P. gingivalis, P. bivia, P. disiens, P. intermedia, P. melaninogenica, P. nigrescens, P. acnes, P. aeruginosa, T. forsythia, S. noxia, T. socranskii and V. cambriense. However , L. crispatus, L. gasseri, L. iners, and L. vaginalis were found at higher counts at sites without BV (p < 0.001).
The relationship between the vaginal microflora and gingivitis
Significantly higher vaginal bacterial counts (p < 0.001) were found for 49/74 species (23 from panel 1 and 26 from panel 2) in BV+ women with a concurrent diagnosis of gingivitis as compared to women who neither had BV nor gingivitis. At the p < 0.001 level this included in addition to those reported above the following species: A. vaginae, B. brevis, C. nigricans, Dialister sp., E. saburreum, L. buccalis, N. mucosa, Petoniphilus sp., P. nigrescens, P. anaerobius, and V. parvula.
Table 2 presents the prevalence rates of bacterial species collected from vaginal samples at the > 1 × 104 detection level demonstrating statistically significant differences by gingival status but independent of BV diagnosis. For 2 of the 74 species tested, P. bivia and P. disiens, higher bacterial counts were observed in subjects with gingivitis (Mann-Whitney U-test, p < 0.001). Trends of differences at the p < 0.01 level were also observed for B. ureolyticus, M. curtisii, M. mulieris, and P. aeruginosa, as well as at the p < 0.05 for G. vaginalis, P. intermedia, P. nigrescens, and V. cambriense. The sensitivity, specificity and odds ratio characteristics of the predictive values for the 6 species with statistically significant odds distinguishing gingival status are presented in Table 3. The remaining 4 species identified in Table 2 failed to qualify. Thus, when P. bivia was present in the vaginal samples, the odds ratio for gingivitis was 3.9 (95% CI 1.5–5.7, p < 0.001). When P. disiens was present in the vaginal samples, the odds ratio for a diagnosis of gingivitis was 3.6 (95%CI: 1.8–7.5, p < 0.001). The corresponding odds ratio for a diagnosis of BV was 5.3 for P. bivia (95%CI: 2.6 to 10.4, p < 0.001) and 4.4 for P. disiens (95% CI: 2.2 to 8.8, p < 0.001).
Table 2
Prevalence of vaginal bacterial species (cut off level: > 1 × 104 cells) for which a significant difference was observed by gingivitis status
Species
No gingivitis
(n = 64)
Gingivitis
(n = 116)
p-value
Prevotella bivia
21.4
43.8
< 0.001
Prevotella disiens
15.7
40.2
< 0.001
Bacteroides ureolyticus
7.1
17.0
< 0.01
Mobiluncus curtisii
15.7
34.8
< 0.01
Mobiluncus mulieris
7.9
24.1
< 0.01
Pseudomonas aeruginosa
10.0
20.5
< 0.01
Gardnerella vaginalis
60.0
67.2
< 0.05
Prevotella intermedia
60.0
69.2
< 0.05
Prevotella nigrescens
10.8
24.3
< 0.05
Varibaculum cambriense
21.4
33.0
< 0.05
Legend: Expressed as percentages.
Table 3
The predictive value of the presence (cut off level: 1 × 104 cells) of P. bivia, P. disiens, M. curtisii, M. mulieris, B. ureolyticus, and V. cambriense in vaginal samples for the diagnosis of gingivitis (20% cutoff level)
Microorganism
Sensitivity
Specificity
Odds ratio
95% CI
P-value
Prevotella bivia
0.18
0.97
3.9
1.7 to 33.8
< 0.001
Prevotella disiens
0.57
0.83
3.6
1.8 to 7.1
< 0.001
Mobiluncus curtisii
0.37
0.83
3.8
1.4 to 5.8
< 0.01
Mobiluncus mulieris
0.26
0.93
4.6
1.8 to 12.6
< 0.01
Bacteroides ureolyticus
0.21
0.93
3.3
1.2 to 9.1
< 0.02
Varibaculum cambriense
0.38
0.77
2.0
1.0 to 4.1
< 0.05
Differences in bacterial levels by differentiation between subjects with any of four BV and gingivitis diagnostic combinations
The distributions of P. bivia and P. disiens in vaginal samples for the four different populations according to combination of vaginal and gingival microflora (BV+/G+, BV-/G-, BV+/G- and BV-/G+) are presented in a boxplot diagram (Figure 1). Analysis by Kruskal-Wallis ANOVA identified differences in bacterial levels at the p < 0.001 level by the combined vaginal and periodontal diagnostic criteria for 49/74 species identified in vaginal samples between BV+/G+ and BV-/G- women and at the p < 0.001 level for the following species: A. actinomycetemcomitans (serotype Y4), A. actinomycetemcomitans (serotype b), A. israelii, A. naeslundii, A. neuii, A. christensenii, A. vaginae, A. odontolyticus, B. ureolyticus, B. biavatii, B. breve, B. longum, C. nigricans, C. aurimucosum, C. gingivalis, C. gracilis, C. ochracea, C. rectus, C. showae, Dialister sp. E. coli, E. corrodens, E. saburreum, F. nucl. nucleatum, F. nucl. polymorphum, F. nucl. naviforme, F. periodonticum, H. influenzae, L. buccalis, M. curtisii, M. mulieris, Peptoniphilus sp., N. mucosa, P. aeruginosa, P. micra, P. anaerobius, P. mirabilis, P. bivia, P. disiens, P. intermedia, P. melaninogenica, P. nigrescens, P. gingivalis, P. acnes, S. noxia, T. forsythia, T. socranskii, V. cambriense, and V. parvula.
Figure 1
Boxplot diagram demonstrating differences in vaginal load for P. bivia and P. disiens by combined diagnostic criteria (Bacterial vaginosis neg and gingivitis neg (BV-/G-), Bacterial vaginosis pos. and Gingivitis pos. (BV+/G+), Bacterial vaginosis pos. and Gingivitis neg. (BV+/G-), and Bacterial vaginosis neg. and Gingivitis pos. (BV-/G+). (* = extreme outliers, ° = outlier values).
×
Anzeige
Specifically, higher counts in vaginal samples were found in women in the BV+/G+ group in comparison to the BV+/G- group for P. bivia, P. disiens, M. curtisii, and M. mulieris (all at the p < 0.01 level). Further analysis demonstrated that the sum of bacterial load including all 74 species studies was higher in the BV+/G+ group than in the BV+/G- group (p < 0.05), but was also higher than in separate comparisons with the two other possible diagnostic combinations (p < 0.01).
Discussion
The checkerboard DNA-DNA hybridization method has been demonstrated to be useful in studies of changes in vaginal microflora during pregnancy [25, 26]. Checkerboard DNA-DNA hybridization is also commonly used in studies on the oral microflora [i.e. [13, 14, 16‐18, 20]], and has also been used to assess the microflora in synovial fluid of subjects with rheumatoid arthritis [27]. Studies of the bacterial colonization of the oral cavity have shown that Actinomyces sp. [28], Fusobacterium spp. [29], Prevotella sp. [30], Capnocytophaga sp. [31] and T. forsythia [32] are associated with gingivitis.
In accordance with the study by Boggess et al. [25], who also using DNA-DNA hybridization in the assessment of vaginal species the present study identified that B. ureolyticus and M. curtisii were commonly found in vaginal samples. We also indentified that, in women with BV and gingivitis and in comparison with those with BV but not gingivitis, the vaginal samples demonstrated significantly higher counts of bacteria commonly associated with periodontal disease including: A. actinomycetemcomitans (Y4), Fusobacterium sp., P. micra, P. intermeda P. gingivalis, and T. forsythia. The role of these bacteria as potential infectious etiological factors in adverse pregnancy outcomes in the context of oral/gingival infection needs to be further explored as also indicated by others [8, 15]. The fact that some bacterial species were found at higher counts in the vaginal samples of women with BV and gingivitis than among those only with BV may be an important observation suggesting that having gingivitis has an impact on the bacterial load in women with BV.
The prevalence of gingivitis in our study population (62%) was higher than the gingivitis prevalence of 48% reported in NHANES III (National Health and Nutrition Examination Survey) [33]. This may be explained by the ethnic distribution and inclusion of many women with low socio-economic status [34]. Studies that have associated periodontal disease with a risk of preterm birth have used a variety of periodontal diagnostic criteria against which the risk of preterm birth has been considered. One of the problems is that periodontitis usually does not present with unequivocal clinical evidence of disease until subjects are at about age 40. Gingivitis is common in younger age groups. The inflammatory response in gingivitis is primarily a cellular immune response [35]. Data from one study suggest that treatment of gingivitis in pregnant women significantly reduced the risk of preterm birth [36]. Due to the fact that only 17 of the women with a high risk for a preterm birth complication in the present study delivered preterm, a statistical analysis of the data based on delivery status was not performed.
Anzeige
This is the first study to demonstrate a link between vaginal bacteria and gingivitis. Others have suggested that the hematogenous route allows the spread of opportunistic pathogens from one location to another [35]. It is also plausible that opportunistic bacteria take advantage of host specific factors and colonize wherever growth conditions are suitable. The oral and vaginal environments may provide such similar colonization and growth conditions in a susceptible host. Further studies are warranted to explore the relationship between oral and vaginal microflora and infections. Further studies are warranted to explore the relationship between the oral and vaginal infection patterns and how this may explain why periodontal disease (including gingivitis) may be a potential adjunct cause of adverse pregnancy outcomes [2‐8, 15, 36].
In a recent periodontal intervention study of pregnant women with periodontitis, the data failed to demonstrate that periodontal intervention had an impact on pregnancy outcomes [37]. Treatment was also restricted to mechanical subgingival debridement and may not have affected bacterial presence in relation to persistent gingivitis, or reduced gingivitis to levels < 20% used as criteria in the present study. Although the survival rate of premature neonates has improved greatly in developed countries, the prevalence of preterm birth rates have not declined and various intervention studies to control for BV and other risk factors have not been successful [38]. Thus, significantly reducing preterm births may require a broader approach to care not limited to vaginal conditions but also include oral infections such as gingivitis.
Conclusion
Women with a diagnosis of BV have a higher proportion of tooth surfaces with evidence of gingivitis
Women with BV and gingivitis and in comparison to those without BV and gingivitis have higher vaginal bacterial counts including bacteria commonly associated with both BV periodontal disease than women with BV but without a diagnosis of gingivitis
P. bivia, and P. disiens, may be of importance in women with both BV and gingivitis.
Acknowledgements
The Clinical Research Foundation (CRF) at the University of Bern, Switzerland, the Foundation for Scientific Research (FWO), Flanders, Belgium (G.01.79.04), and the National Institutes of Health (HD-41682) and the NIDCR grant P30 DEO 9743 funded the study.
Anzeige
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GRP, JH, DE, MV, MT and RV designed the study. MR collected clinical dental data and JH was in charge of medical examinations. REP analyzed the radiographs and defined the periodontal diagnosis. KP coordinated the study and established the clinical database (medical and dental). MW and RH processed the microbiological material and developed the probes. RV, MT and MV provided and confirmed the accuracy of the bacteria. GRP was responsible for the data analysis. All co-authors contributed to the preparation of the manuscript.
Rutger Persson Jane Hitti Rita Verhelst Mario Vaneechoutte Rigmor Persson Regula Hirschi Marianne Weibel Marilynn Rothen Marleen Temmerman Kathleen Paul David Eschenbach
In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.
Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.
Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.
Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.
Update Innere Medizin
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
